Exact Sciences (EXAS) Prelim. Q4 Revenue Tops Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/13/2026
- Wall Street set for lower open as Iran tensions jolt sentiment; chip stocks fall
- SK Hynix’s record plunge drags down global chip stocks
- Oil gains over 3% as fresh military strikes threaten Hormuz shipments
- Ditching streaming could boost Disney stock by 40%, Wells Fargo says
- AstraZeneca stock dips as HSBC downgrades stock on 'tough path ahead'
Exact Sciences Announces Preliminary Fourth Quarter 2019 Results
January 12, 2020 7:00 PM ESTMADISON, Wis., Jan. 12, 2020 /PRNewswire/ --Â Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company expects to report revenue between $294 million and $296 million for the fourth quarter ended Dec. 31, 2019.
"Building off a transformative 2019, Exact Sciences is uniquely positioned to change the way... More
